Filing Details

Accession Number:
0001179110-12-017082
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-06 20:20:19
Reporting Period:
2012-12-06
Filing Date:
2012-12-06
Accepted Time:
2012-12-06 20:20:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Depomed Inc DEPO Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420228 Md Michael Sweeney 7999 Gateway Boulevard, Suite 300
Newark CA 94560
Cmo And Vp, R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-12-06 1,418 $5.77 5,315 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock. The sales reported in this Form 4 were sold pursuant to a rule 10b5-1 trading plan adopted by the reporting person in September 2012.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.75 to $5.79. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
  3. Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.